Association between the plasma proteome and plasma α-tocopherol concentrations in humans
Tài liệu tham khảo
Kuzyk, 2009, Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma, Mol Cell Proteomics, 8, 1860, 10.1074/mcp.M800540-MCP200
Didangelos, 2009, Proteomics of acute coronary syndromes, Curr Atheroscler Rep, 11, 188, 10.1007/s11883-009-0030-x
Mayr, 2004, Vascular proteomics: linking proteomic and metabolomic changes, Proteomics, 4, 3751, 10.1002/pmic.200400947
García-Bailo, 2011, Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: Modulation of inflammation and oxidative stress, Biologics, 5, 1
Traber, 1999, Molecular mechanisms of vitamin E transport, Annu Rev Nutr, 19, 343, 10.1146/annurev.nutr.19.1.343
Thomas, 2000, Molecular action of vitamin E in lipoprotein oxidation: Implications for atherosclerosis, Free Radic Biol Med, 28, 1795, 10.1016/S0891-5849(00)00236-7
Devaraj, 1999, α-Tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase, Arterioscler Thromb Vasc Biol, 19, 1125, 10.1161/01.ATV.19.4.1125
Singh, 2005, Vitamin E, oxidative stress, and inflammation, Annu Rev Nutr, 25, 151, 10.1146/annurev.nutr.24.012003.132446
Gaziano, 2004, and cardiovascular disease: observational studies, Ann N Y Acad Sci, 1031, 280, 10.1196/annals.1331.028
Mayer-Davis, 2002, Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS), Diabetes Care, 25, 2172, 10.2337/diacare.25.12.2172
Bjelakovic, 2007, Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis, J Am Med Assoc, 297, 842, 10.1001/jama.297.8.842
Ainsworth, 1993, Compendium of physical activities: classification of energy costs of human physical activities, Med Sci Sports Exerc, 25, 71, 10.1249/00005768-199301000-00011
Cahill, 2009, Vitamin C deficiency in a population of young canadian adults, Am J Epidemiol, 170, 464, 10.1093/aje/kwp156
Liu, 2011, Simultaneous measurement of three tocopherols, all-trans-retinol, and eight carotenoids in human plasma by isocratic liquid chromatography, J Chromatog Sci, 49, 221, 10.1093/chrsci/49.3.221
García-Bailo, 2012, Dietary patterns and ethnicity are associated with distinct plasma proteomic groups, Am J Clin Nutr, 95, 352, 10.3945/ajcn.111.022657
Bruno, 2005, Alpha-tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status, Am J Clin Nutr, 81, 95, 10.1093/ajcn/81.1.95
Fuss, 2001, Fibrinogen: structure, function, and surface interactions, J Vasc Interv Radiol, 12, 677, 10.1016/S1051-0443(07)61437-7
Corbett, 1998, Fibronectin-fibrin cross-linking: a regulator of cell behavior, Trends Cardiovasc Med, 8, 357, 10.1016/S1050-1738(98)00028-0
Lowe, 2004, Plasma fibrinogen, Ann Clin Biochem, 41, 430, 10.1258/0004563042466884
Folsom, 2001, Hemostatic risk factors for atherothrombotic disease: an epidemiologic view, Thromb Haemost, 86, 366, 10.1055/s-0037-1616234
Danesh, 1998, Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies, J Am Med Assoc, 279, 1477, 10.1001/jama.279.18.1477
Maresca, 1999, Measuring plasma fibrinogen to predict stroke and myocardial infarction: An update, Arterioscler Thromb Vasc Biol, 19, 1368, 10.1161/01.ATV.19.6.1368
Packard, 2000, Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease, N Eng J Med, 343, 1148, 10.1056/NEJM200010193431603
Keaney, 1999, Vitamin E and vascular homeostasis: Implications for atherosclerosis, FASEB J, 13, 965, 10.1096/fasebj.13.9.965
Leichtle, 2006, Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects, J Am Coll Nutr, 25, 420, 10.1080/07315724.2006.10719555
de Oliveira Otto, 2011, Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis, J Nutr, 141, 1508, 10.3945/jn.111.138115
Schmidt, 2007, The interrelated role of fibronectin and interleukin-1 in biomaterial-modulated macrophage function, Biomaterials, 28, 371, 10.1016/j.biomaterials.2006.08.041
Maurer, 2010, Emerging roles of fibronectin in thrombosis, Thromb Res, 125, 287, 10.1016/j.thromres.2009.12.017
Villacorta, 2003, α-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-α-mediated downregulation in human smooth muscle cells, Circ Res, 92, 104, 10.1161/01.RES.0000049103.38175.1B
Frazier, 1996, Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor, J Invest Dermatol, 107, 404, 10.1111/1523-1747.ep12363389
De Cristofaro, 2002, Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects, Thromb Haemost, 87, 58, 10.1055/s-0037-1612944
Rota, 1998, Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E, Blood, 91, 508, 10.1182/blood.V91.2.508
Ginsberg, 1986, Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo, J Clin Invest, 78, 1287, 10.1172/JCI112713
Wang, 1985, Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III, J Clin Invest, 75, 384, 10.1172/JCI111711
Shachter, 2001, Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism, Curr Opin Lipidol, 12, 297, 10.1097/00041433-200106000-00009
Kawakami, 2009, Apolipoprotein CIII links dyslipidemia with atherosclerosis, J Atheroscler Thromb, 16, 6, 10.5551/jat.E607
Chan, 2008, An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?, Int J Clin Pract, 62, 799, 10.1111/j.1742-1241.2007.01678.x
Olivieri, 2010, Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation, J Thromb Haemost, 8, 463, 10.1111/j.1538-7836.2009.03720.x
Borel, 2009, Br J Nutr, 101, 680, 10.1017/S0007114508030754
Major, 2011, Genome-wide association study identifies common variants associated with circulating vitamin E levels, Hum Mol Genet, 20, 3876, 10.1093/hmg/ddr296
Ishioka, 1986, Amino acid sequence of human plasma α1B-glycoprotein: homology to the immunoglobulin supergene family, Proc Natl Acad Sci U S A, 83, 2363, 10.1073/pnas.83.8.2363
Tian, 2008, Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients, BMC Cancer, 8, 241, 10.1186/1471-2407-8-241
Kreunin, 2007, Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling, J Proteome Res, 6, 2631, 10.1021/pr0700807
Yoon, 2006, Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags, Int J Oncol, 29, 315
Abdul-Rahman, 2007, Expression of high-abundance proteins in sera patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods, Electrophoresis, 28, 1989, 10.1002/elps.200600629
Puchades, 2003, Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease, Mol Brain Res, 118, 140, 10.1016/j.molbrainres.2003.08.005
Freedman, 1996, α-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism, Circulation, 94, 2434, 10.1161/01.CIR.94.10.2434
Traber, 2008, Vitamin E revisited: do new data validate benefits for chronic disease prevention?, Curr Opin Lipidol, 19, 30, 10.1097/MOL.0b013e3282f2dab6